Quantuvis

📢 Are You Participating in Global Biosimilars Week? 📊 This is an  exciting campaign from the International Generics and Biosimilar Medicines Association with the mission to raise awareness of the powerful and lifechanging impact of biosimilar medicines. Our team at Quantuvis have registered for a few online sessions to continue deepening our knowledge and understanding of the biosimilars market as we support our clients ✔ We would be happy to share how we are currently supporting our clients within the Biosimilars field to drive launch readiness between market access and field sales and scale their overall market strategy.  Let us know if you want to connect and discuss! 

📢 Are You Participating in Global Biosimilars Week? 📊 This is an  exciting campaign from the International Generics and Biosimilar Medicines Association with the mission to raise awareness of the powerful and lifechanging impact of biosimilar medicines. Our team at Quantuvis have registered for a few online sessions to continue deepening our knowledge and understanding of the biosimilars market as we support our clients ✔ We would be happy to share how we are currently supporting our clients within the Biosimilars field to drive launch readiness between market access and field sales and scale their overall market strategy.  Let us know if you want to connect and discuss! 

🔊 In our most recent interactive webinar led by Quantuvis CEO Sandeep Patel and our industry guest Cort Morrison we discussed different solutions and techniques for understanding and effectively executing patient acquisition and access strategies.  📌 We also discussed some immediate action points for your teams that you can start implementing today. Have a look at the recording to learn more ➡ https://lnkd.in/gSB9zZkS Let us know if you want to connect to discuss this further! 🤝

📢 This Thursday at 2:00 PM ET we are hosting an interactive discussion with an industry expert Cort Morrison and our CEO Sandeep Patel.    We will explore solutions and techniques to elevate your patient acquisition and access strategies:  ➡ What actions can you take to strengthen the collaboration between the Market Access and Finance teams, leading to greater accuracy in forecasting?   ➡ What common challenges arise in your current pricing and contracting process, and how can you turn them into opportunities for improvement?    ✅ Register today and secure your spot - https://lnkd.in/gdvf9tfp   

📌 How do you currently evaluate the trade-offs in your patient acquisition strategy to minimize duplicative spending?   📌 What specific steps can you take to improve coordination between the Market Access and Finance teams for better forecasting accuracy?   📌 What are the common errors that occur in your current pricing and contracting process, and how can you address them?     ✅ We will discuss these topics and more during our interactive discussion on November 7th at 2 PM ET.   📢 Don’t miss this opportunity to enhance your team’s capabilities and drive impactful results! Learn from the industry expertise of Sandeep Patel and Cort Morrison.    Register here ➡ https://lnkd.in/gdvf9tfp  

📢 Join us for our upcoming Thought Leadership Webinar and Interactive Discussion designed for Market Access and Finance teams. Register here ➡ https://lnkd.in/gdvf9tfp 🗣 The discussion will be led by Sandeep Patel CEO of Quantuvis, in collaboration with our industry guest, Cort Morrison Market Access Contract and Analytics Lead at Corium. 📊 During this webinar, we will explore solutions and techniques for understanding and effectively executing your patient acquisition and access strategies, including:    📌 Evaluating patient acquisition strategy trade-offs to reduce duplicative spend and fine-tune GTN  📌 Coordinating between Market Access and Finance teams to enhance forecasting accuracy, reduce errors, and align contract strategies with organizational objectives  📌 Ensuring precise data interoperability among relevant transaction, access, and contract datasets to support rebate investment strategies

💡 Innovation in healthcare is one of many market headwinds that challenge the traditional experience-driven operating models, and it is also often measured by disruption, with constant pursuit of breakthrough treatments that could change the landscape.    📉 Today, new interchangeable biosimilar treatments are readily available and are aiming to take market share from established originator brands. Beginning next year, Express Scripts, the pharmacy services business of Evernorth, will take additional steps to support patient access to low-cost biosimilars while excluding Humira on its largest commercial formularies.      🔎 What tools do you and our team have to address various market headwinds and validate your overall strategy? Whether you’re launching a biosimilar, innovative brand, or facing competitive entrants, Quantuvis’ contract forecasting and share-shift tools enables you to make evaluate market complexities to make the right pricing and contracting decisions.  #strategy #marketaccess

📊 Two years have passed since the Inflation Reduction Act was approved, and a change concerning biosimilar reimbursement rates was put in place in 2022.  The new provision aimed to remove financial barriers to biosimilar adoption and potentially save the U.S. healthcare system billions of dollars.   However, has the legislation achieved its goals so far? A recent survey by Certara looked at the use of 17 biosimilar products targeting five reference medicines.  📌 Biosimilars are entering highly competitive markets where PBMs have well-established contracts with reference drugs. PBMs are accustomed to the substantial revenue from rebates provided by these brands, and many of their contracts likely take into account market share volumes. To succeed in this space, it will be crucial for pharma companies to develop effective channel strategies and tailored solutions to ensure access and uptake. This requires getting payer contracts right from the outset. ✔ At Quantuvis, we’ve developed a solution specifically designed for pricing & market access teams. By leveraging your existing data assets — we combine these sources into a cloud-based technology platform to enable in-house analytics. This platform supports key initiatives like Market Opportunity & Strategy Development, Contract Development & Execution, and Access & Contract Pull-Through. #marketaccess #pricing #contracting #pullthrough

🔊 In our most recent thought leadership webinar, we discussed several strategies for navigating market challenges, particularly those arising from current and potential regulations. 📈 How does your team achieve the desired revenue and portfolio performance results while considering the impact on patient acquisition costs from a comprehensive perspective, rather than just a pure GTN viewpoint? 💾 Check out the recording here - https://rb.gy/bpxi3p

✔ Are you planning to attend the PCMA Annual Meeting 2024 in Phoenix next week? Corrado Panno from Quantuvis will be in attendance and is looking forward to networking opportunities. 🤝 Let us know if you would like to schedule an in-person meeting!